In a world-wide context where governments and funding agencies prioritize support to translational science-even for illnesses with poorly understood mechanisms-at the expense of hypothesis-driven questions on fundamental biology, political decisions to launch large-scale programs addressing crucial questions about the brain are to be celebrated. This change in paradigm stands in line with the reality that we must understand the brain in depth before therapies to heal disease and trauma can be developed. How can we get the most out of this unique scenario emerging in wealthy countries, and how could developing countries be integrated into this new era? Science is a universal endeavor that benefits from diversity, because problems are faced from different perspectives, focuses, priorities, and resources. Understanding the healthy and diseased brain is a goal for the entire international neuroscience community. For agencies pioneering these initiatives, an important challenge is to distribute resources in a manner that fosters significant discovery. Substantial grants-individual or collective-awarded to high-risk hypothesis-driven projects selected through transparent peer review will be more efficient than megaprojects concentrated in a few laboratories. In developing countries, it is compelling to establish competitive neuroscience programs embracing the same philosophy to tackle fundamental problems and minimize the technological gap that separates us from the developed world, providing a bridge to join this ongoing brain revolution.
Learning from Physics

Tobias Bonhoeffer
Max-Planck-Institut f€ ur Neurobiologie
In recent years it has been more and more realized that some questions in brain research are such that it is almost mandatory to address them in big consortia. This approach, while common in some parts of physics, has only very rarely been used in the biosciences (with the notable exception of the Human Genome Project). Therefore, we have limited experience with it. Upscaling is not trivial because it is not only a matter of simple numbers. For instance, how and how freely scientific results are shared has to be different in larger projects and a distinctly different culture has to be implemented to achieve this. Our reward system, which currently lies in being first to publish, incentivizes secrecy rather than openness. This needs to be changed, perhaps in general for the benefit of science, but certainly within large-scale projects. The biomedical community can learn a lot from their colleagues in physics or from big companies about how to manage big teams, and there are exciting new places for this new type of science to live, such as the Allen Brain Institute or the ChanZuckerberg Science Initiative. That said, not all science in the neurosciences will or should be big. There will be plenty of opportunities where conventional single investigator-based science will be the better way to go. We should not go overboard with big science but embrace and develop modern ways of doing science which includes bigger approaches but also calls for changes in culture and interaction between scientists of different provenance.
Bench to Bedside International Collaborations
Reisa Sperling The past decade has seen an increase in international collaboration to elucidate human brain function and the pathophysiologic processes underlying disease. While much of the previous investment has focused on basic scientific investigations of normal neural function and nonclinical therapeutic development, there is an increasing recognition that international collaborative initiatives will be necessary to translate the findings from this groundbreaking research into much needed therapeutic advances for neurodegenerative and other brain diseases. Several large secondary prevention trials in preclinical Alzheimer's have launched over the past few years, supported through public-private partnerships. These studies have served not only to enhance international collaboration, but also to drive translational science toward the ''endgame'' of finding effective therapies for Alzheimer's and other devastating brain disorders. One of the benefits of these public-private partnerships will be the availability of large trial datasets with multiple biomarkers and cognitive outcomes that should serve to advance the entire field. It is clear that conquering the ''final frontier'' of unlocking the mysteries of the brain and delivering effective treatments to devastating brain diseases will require continued international collaboration, across scientific disciplines, across traditional academic, industry, government, and geographic boundaries, and perhaps most importantly, new models of partnership in clinical research with the people affected by and at risk for these diseases across all cultures.
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Don't Turn Away the Anarchists
Yadin Dudai
Weizmann Institute of Science and New York University Evolution offers both opportunities and risks. In becoming big science, neuroscience experienced a transition in its evolution as a scientific (meta) discipline, perhaps the most significant one since conceptual and methodological mutations made molecular neuroscience a reality. Mega-funding initiatives reflect not only the urge of the public to understand the brain, harness its potential, and ameliorate its defects, but also the willingness of societies and individuals to commit resources. Potential gains are well appreciated, caveats less so. Appreciating risks may preempt them. The points that concern me in the midst of the explosion of data (e.g., in my field, brain underpinnings of memory) concern the nature of our scientific culture and its potential effects on PIs and paradigms. Becoming so costly and capital and labor intensive, adventures in the forefront of neuroscience may acquire characteristics of classic corporate culture. Yet many pioneers in science selected their life-long occupation and excel in it because they are idiosyncratic intellectual loners. How will big (neuro)science accommodate the anarchists? How will massively invested trends escape paradigmatic traps? Preventive medicine to these potential problems may involve a spectrum of immunizations and remedies. They could include pre-set allocations of significant funding to outliers; better education in the history of scientific paradigms and in the sociology, psychology, and ethics of team efforts; and training to devote time for reflective, irritating devil's advocate moments, even if your papers make it into Neuron.
Understanding the Developing Brain
Oscar Marín
MRC Centre for Neurodevelopmental Disorders at King's College London
Global data-gathering approaches are not incompatible with bottom-up, investigatordriven research, and they are both important to drive scientific discovery. Some fields in neuroscience have matured to a point in which they will surely benefit from collective approaches, but the cost of these efforts should not come at the expense of blue-sky research led by individual researchers. Politicians and entrepreneurs are attracted by the possibility of ''directing'' discovery in particular directions through visionary projects that receive a lot of media attention, but this is not always the most effective way of funding scientific research. In Europe, for example, I am convinced that the funding provided by the European Research Council to individual scientists will have a much larger long-term impact on society that any of the current large-scale brain initiatives. In addition, global brain initiatives around the globe so far have almost exclusively focused on the adult brain. While understanding brain functioning is an ultimate frontier in neuroscience, it is unlikely that we will be able to prevent or cure many psychiatric disorders that are caused by abnormal brain development (ADHD, autism, schizophrenia, to name a few) if we limit our attention to the adult brain. Global initiatives are needed to coordinate studies on the emergence of brain function during development in both health and disease.
Organizational Challenges
Richard Morris
University of Edinburgh
Neuroscience is going viral but there are organizational challenges. New private and public initiatives across the world offer a wonderful opportunity to address both needs-driven and basic science issues and to capitalize on the amazing new technologies that are at hand. In Europe, the European Research Council is funding Investigators at different stages of their career, the new FENS/KAVLI Network of Excellence is identifying rising stars, and several major laboratory initiatives started in Bordeaux, Frankfurt, Lisbon, and London. The Champalimaud Institute in Lisbon and the SainsburyWellcome Centre in London offer the promise of focused research on the major basic science problem of understanding how neural circuits and behavior operate. This comes at a time when there are pressing needs in the mental health domain. In the United Kingdom, and elsewhere in Europe, a major proportion of national health budgets goes toward the care and management of mental illness. Organizations such as ''MQ: Transforming mental health'' are catalyzing discussions about new approaches, discussing co-funding opportunities with public funders, and seeking public support. As we move from small groups led by one person to larger teams with more distributed responsibility, the organization and ownership of scientific work needs to change. Greater investment will come to our rescue, but inspired and transparent leadership will be required in Universities and Research Institutes.
More than the Sum of the Parts
Thomas Mrsic-Flogel Sainsbury Wellcome Centre for Neural Circuits and Behaviour, Biozentrum, University of Basel New technologies are generating a wealth of data about synapses, dendrites, cell types, and the complex circuits they form, at an unprecedented pace. Yet there is very little understanding about how these elements combine to generate the activity patterns that underlie perception, cognition, and action. A crucial next step is to integrate existing and emerging knowledge into coherent theories that explain how neural circuits generate a rich repertoire of instinctive and adaptive behaviors. These theories must be biologically plausible, experimentally testable, and unify research across multiple levels of analysis and must therefore be forged through close interactions between experimentalists and theorists. The prevailing culture encourages individuals to compete for limited resources while striving for recognition. Current models of funding are being revised to spur on large-scale efforts in neuroscience, epitomized by the establishment of several research institutes with specific research visions and approaches. Global funding initiatives may help coordinate research that cannot be carried out in individual labs, for example, by supporting the creation of atlases and databases (e.g., cell-type profiling and circuit anatomy across species, repositories for genetic and viral tools), and technology development (e.g. high-density electrodes). However, methods and databases are not enough-conceptual breakthroughs require support for the freedom and creativity of individual labs in addition to new collective research programs on the global scale.
